Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 25 of Phio Pharmaceuticals Corp.'s SEC filings and found 26 warrant series, 1 convertible, 1 ATM program, 3 shelf registrations, 2 S-1 registrations and 5 completed offerings on file for PHIO. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Sep 15, 2026.
DilutionScan ProEvery instrument in full ยท $59/mo
Covered companies in Biotechnology. All tickers A to Z
GTBPGT Biopharma, Inc.
INTIInhibitor Therapeutics, Inc.
ICUSeaStar Medical Holding Corporation
CALCCalciMedica, Inc.
GDTCCytoMed Therapeutics Limited Ordinary Shares
PASGPassage Bio, Inc.
TVRDTvardi Therapeutics, Inc.
INTSIntensity Therapeutics, Inc.
CLGNCollPlant Biotechnologies Ltd Ordinary Shares
INABIN8bio, Inc.
BLRXBioLineRX Ltd
PTNPalatin Technologies, Inc.
LTRNLantern Pharma Inc.
LSTALisata Therapeutics, Inc.
BCLIBrainstorm Cell Therapeutics Inc.